ArticleJournal of cancer research and clinical oncology2025

Preclinical pharmacokinetics and in vitro ADME properties of PAT-1102: a novel HDAC inhibitor for cancer therapy.

Chandrashekar Mataguru Doreswamy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.